gabexate has been researched along with Pemphigus in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Naito, K | 1 |
1 other study available for gabexate and Pemphigus
Article | Year |
---|---|
[The identification of inhibitors of acantholysis of pemphigus vulgaris].
Topics: Acantholysis; Animals; Fibrinolysin; Gabexate; Guanidines; Humans; Mice; Mice, Inbred BALB C; Pemphi | 1987 |